ACE inhibitors on heavy market competition.

Published: 2001-06-14 06:59:00

Updated: 2001-06-14 06:59:00

The market share of ACE (Angiotensin II) inhibitor drugs showed about 10% last year out of the total 320 billion won of anti-hypertensive drug markets (including diuretics), and estimated to run up to 20to 30% this year.

MSD's Cozaar (Losartan) was introduced in Korea in Sept. 1997 and registe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK